Biogen Inc. is significantly expanding its West Coast presence by establishing an immunology hub in South San Francisco, building on its $1.5 billion acquisition of Human Immunology Biosciences (HI-Bio) last year. The Cambridge-based pharmaceutical company plans to nearly triple its footprint in the area, growing from approximately 9,000 square feet to 24,500 square feet at […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
The U.S. arm of LVMH’s flagship fashion house has bought the six-story...
ByThe RegistryOctober 19, 2026High Street Residential and Barings have started construction on two apartment buildings...
ByThe RegistryOctober 19, 2026The 302-bed medical center would anchor Sutter’s $2.8 billion two-campus expansion in...
ByThe RegistryOctober 19, 2026Samsung has bought a power-equipped R&D building near the Tasman light rail...
ByThe RegistryOctober 19, 2026